NIH-funded research R21 grant

Creating ultra-thin and reliable bioelectronic interfaces for patients

Official title: Manufacturing Process for Ultra-Thin, Ultra-Reliable, and Implantable Liquid-Crystal-Polymer-Based Bioelectronic Interfaces

Funded at University of Florida · NIH-11128999 · Data updated 2026-11-12

This study is working on creating super-thin and flexible devices that can help people with brain or nerve issues connect better with machines, like prosthetic limbs, so they can move and feel more naturally throughout their lives.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startMay 1, 2025
Project endApril 30, 2027
Funding year2025
Award (this year)$214,408
NIH project number1R21EB037322-01
Project IDNIH-11128999 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with neurological conditions requiring brain-machine interfaces or those needing advanced prosthetic limb control.

Less likely to help

Patients with conditions unrelated to neural interfaces or those who do not require sensory or motor function restoration may not benefit from this research.

What this research studies

This research focuses on developing advanced bioelectronic interfaces that are extremely thin, flexible, and reliable for patients needing neural connections. The project aims to enhance the manufacturing processes of these interfaces, making them suitable for various clinical applications, including brain-machine interfaces and prosthetic limb control. By improving the technology used to create these devices, the research seeks to ensure they can function effectively throughout a patient's life with minimal tissue response. Patients may benefit from improved sensory and motor function restoration through these innovative devices.

Why it matters

Potential benefit: If successful, this research could lead to more effective and long-lasting neural interfaces that significantly improve the quality of life for patients with sensory and motor function impairments.

How similar studies have gone: Previous research has shown promise in developing bioelectronic interfaces, but this specific approach to ultra-thin manufacturing is innovative and largely untested.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Judy, Jack W — University of Florida
  • Study coordinator: Judy, Jack W

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.